
Science&Humans closes oversubscribed $10M Series A as hormone health moves into the mainstream
Canadian healthcare technology company Science&Humans has closed an oversubscribed $10M Series A round, combining equity and debt financing, as investor and employer interest in hormone health accelerates.



